TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805).

Wenxin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.